Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.
Co-morbidities
Dinesh Khullar , Anish Kumar Gupta , Kulwant Singh
Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al
Harriette Van Spall, Mikhail Kosiborod
Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan
Aleksandra Bykova , Maria Serova , Maria Chashkina , et al
Biykem Bozkurt, Muthiah Vaduganathan, , et al
Carolyn Lam, Scott Solomon, John JV McMurray, et al
David K Ryan , Debasish Banerjee , Fadi Jouhra
James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al
Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al
Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al
Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al
About
Media
James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al
Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al
Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al
Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al
Carolyn Lam, Scott Solomon, John JV McMurray, et al
Harriette Van Spall, Javed Butler, Faiez Zannad, et al
Media
Harriette Van Spall, Mark Petrie
Harriette Van Spall, Mikhail Kosiborod
Biykem Bozkurt, Muthiah Vaduganathan, , et al
Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al
Articles
Finerenone: Will It Be a Game-changer?
Published:
23 December 2024
Citation:
Cardiac Failure Review 2024;10:e19.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views:
1574
- Downloads:
145
-
Read time: 21m 40s
Aldosterone and Potassium in Heart Failure
Published:
20 December 2024
Citation:
Cardiac Failure Review 2024;10:e18.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views:
842
- Downloads:
94
-
Read time: 37m 48s
Mineralocorticoid Receptor Antagonists in Heart Failure
Published:
12 November 2024
Citation:
Cardiac Failure Review 2024;10:e15.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views:
1414
- Downloads:
171
-
Read time: 19m 41s
GLP-1RA in Different HFpEF Phenotypes
Published:
16 October 2024
Citation:
Cardiac Failure Review 2024;10:e14.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views:
1176
- Downloads:
148
-
Read time: 22m 11s